期刊文献+

慢性阻塞性肺疾病大鼠骨骼肌中NF-κB通路的研究 被引量:1

The NF-κB Pathway Activated in the Skeletal Muscle of COPD Rats
下载PDF
导出
摘要 目的:研究COPD大鼠骨骼中磷酸化NF-κB通路蛋白的表达情况及意义。方法:采用气管内滴入脂多糖+反复熏香烟法复制COPD大鼠动物模型。Western blot方法测定大鼠骨骼肌内磷酸化NF-κB蛋白的表达,ELISA法测定大鼠血清及膈肌中IL-1β的表达。结果:Western blot结果显示,COPD大鼠骨骼肌中磷酸化NF-κB蛋白的表达均较对照组明显升高(P<0.01);ELISA结果显示,IL-1β在血清及骨骼肌中的表达均升高(P<0.01);NF-κB与IL-1β水平呈显著正相关(r=0.55,P<0.01)。结论:COPD大鼠骨骼肌中NF-κB表达上调,IL-1β可激活骨骼肌中NF-κB通路。 Objective: To study the role of NF-κB pathway in the skeletal muscle of COPD rats. Methods: The COPD rat model was established by instillation of LPS and exposure to cigarette smoke for 28 days. The protein levels of NF- K B in the skeletal muscle were measured by Western blot. The concentration of IL-1 β in serum and diaphragm were measured by ELISA. Results: Western blot resuit showed that, in the skeletal muscle, compared with the normal control group, the protein expression of NF-K B increased significantly in the model group(P〈0.01). Compared with the normal control group, in the serum and the diaphragm, the IL-1βwere significantly higher than those of the control group(P〈0.01). NF- κB was significantly positively correlated with the IL-1β (r=0.55, P〈0.01). Conclusion: The data shows that the NF-K B pathway is up-regulated in the skeletal muscle of COPD rats, and IL-1β may activate NF- κB pathway in skeletal muscle.
出处 《中国医学创新》 CAS 2012年第18期15-17,共3页 Medical Innovation of China
基金 广东省自然科学基金(项目编号:10151006001000012) 广州市医药卫生科技项目(项目编号:201102A213099)
关键词 慢性阻塞性肺疾病 骨骼肌 NF-ΚB IL-1Β 大鼠 COPD Skeletal muscle NF- κB pathway IL-1β Rat
  • 相关文献

参考文献7

  • 1Schols A MWJ,Broekhuizen R,Weling-Scheepers C A. Body composition and mortality in chronic obstructive pulmonary disease[J].American Journal of Clinical Nutrition,2005,(01):53-59.
  • 2Cai D,Frantz J D,Tawa NE Jr. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice[J].Cell,2004,(02):285298.doi:10.1016/j.cell.2004.09.027.
  • 3Aggarwal B B,Takada Y,Shishodia S. Nuclear transcription factor NF-kappa B:role in biology and medicine[J].Indian Journal of Experimental Biology,2004,(04):341-353.
  • 4Yaron A,Hatzubai A,Davis M. Identification of the receptor component of the IκBα-ubiquitin ligase[J].Nature,1998,(6711):590-594.doi:10.1038/25159.
  • 5范伟,刘朝晖,张溪林,梁志科,曾祥富.慢性阻塞性肺疾病大鼠膈肌萎缩信号通路与白细胞介素17相关性的研究[J].中国呼吸与危重监护杂志,2011,10(6):527-532. 被引量:8
  • 6Brian Skaug,Xiaomao Jiang,Zhijian J Chen. The role of ubiquitin in NF-κB regulatory pathways[J].Annual Review of Biochemistry,2009,(78):769-796.
  • 7Agusti A,Morla M,Sauleda J. NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight[J].Thorax,2004,(06):483-487.doi:10.1136/thx.2003.017640.

二级参考文献25

  • 1Stubbings AK, Moore A J, Dusmet M, et al. Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease..T Physio1,2008 ,586 :2637-2650.
  • 2Hellings PW, Kasran A, Liu Z,et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol,2003,28:42- 50.
  • 3Liu C, Qian W, Qian Y,et al. Actl ,a U-box E3 Ubiquitin Ligase for IL-17 Signaling. Sci Signal,2009,2:92-ra63.
  • 4Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:Gold executive summary. Am J Respir Crit Care Med ,2007,176:532-555.
  • 5Schols A, Broekhuizen R, Weling-Scheepers CA, et al. Body compositinon and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr,2005,82:53-59.
  • 6Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Repir J,2008,31:492-501.
  • 7Laghi F,Tobin MJ. Disorder of the respiratory muscles. Am J Repir Crit Care Med,2003,168 : 10-48.
  • 8Ottenheijm C, Heunks L, Sieck GC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006,173:527-534.
  • 9Acharyya S, Ladner K J, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest ,2004,114:370-378.
  • 10Hershko A. Ubiquitin:ro|es in protein modification and breakdown. Cell, 1983,34 : 11-12.

共引文献7

同被引文献15

  • 1SEN R, BALTIMORE D. Multiple nuclear factors interact With the immunoglobulin enhancer Sequences [J]. Cell, 1986, 46(5):705-716.
  • 2AMEYA PARANJPE, KALKUNTE S, SRIVENUGOPAL. Degradation of NF-KB, p53 and other regulatory redox- sensitive proteins by thiolconjugating and nitrosylating drugs in human tumor cells [J]. Carcinogenesis, 2013, 34 (5):990-1000.
  • 3AMIRI K I, RICHMOND A. Role of nuclear factor-kappa B in melanoma[J]. Cancer Metastasis Rev, 2005, 24: 301- 313.
  • 4KALALTZIDIS D, GILMORE T D. Transcription factor cross-talk: the estrogen receptor and NF-kappa B[J]. Trends Endocrinol Metab, 2005,16:46-52.
  • 5KUO M T, LIU Z, WEI Y, et al. Induction of human MDR1 gene expression by 2-acelylaminofluoxene is medi- ated by effectors of the phosphoinositide 3-kinase Path- way that activate NF-kappa signaling [J]. Oncogene, 2002,21(13):1945-1954.
  • 6LAVON I, PIKARSKY E, GUTKOVICH E, et al. Nucle- ar fator-kappaB Protects the liver against genotoxic stress and functions independently of p53 [J]. Cancer Res, 2003,63 (1): 25-30.
  • 7AE-RI N, KATINKA P Z, PAUL P T, et al. Non-canoni- cal NF-KB signaling in endothelial cells may enhance sy- novial inflammation by stimulating angiogenesis[J]. Jour- nal of Translational Medicine, 2011,9(2):50.
  • 8杜伟,袁贵斌,汪永平,叶云,刘灿.介入法植入国产支架治疗前列腺增生症的临床应用[J].大理学院学报(综合版),2010,9(2):47-49. 被引量:2
  • 9齐京鹏,廖和和,王永峰,武文辉,张学成.不能手术的原发性肝癌介入治疗与介入加放疗的疗效比较[J].现代肿瘤医学,2011,19(3):528-530. 被引量:20
  • 10独建库,李冠海,张明德,李珂,马小桔.肝癌1063例介入治疗并发症处理的研究[J].临床军医杂志,2011,39(3):491-493. 被引量:6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部